Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the treatment of obesity. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://estelleahwp019383.getblogs.net/71419260/semaglutide-a-potential-solution-for-metabolic-disorders